Corporate Information And Statement Of Ifrs Compliance [Abstract]

BioInvent International - Filing #678852

Concept	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	BioInvent	—
Legal form of entity	—	AB (publ)	—
Address of entity's registered office	—	Ideongatan 1, Lund	—
Principal place of business	—	Sverige	—
Description of nature of entity's operations and principal activities	—	BioInvent International AB (Nasdaq Stockholm: BINV) är ett	—
Statement of IFRS compliance [text block]	—	UTTALANDE OM ÖVERENSSTÄMMELSE MED TILLÄMPADE	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	11 844 SEK	—	11 506 SEK
Current trade receivables	11 930 SEK	—	15 780 SEK
Current trade payables	29 189 SEK	—	41 346 SEK
Disclosure of material accounting policy information [text block]	—	Not 1	—
Disclosure of objectives, policies and processes for managing capital [text block]	—	Kapitalhantering	—